Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.

OBJECTIVE: The pathogenetic mechanisms of sporadic somatotroph adenomas are not well understood, but derangements of the cAMP pathway have been implicated. Recent studies have identified L206R mutations in the alpha catalytic subunit of protein kinase A (PRKACA) in cortisol-producing adrenocortical...

Full description

Bibliographic Details
Main Authors: Larkin, S, Ferraù, F, Karavitaki, N, Hernández-Ramírez, L, Ansorge, O, Grossman, A, Korbonits, M
Format: Journal article
Language:English
Published: 2014
_version_ 1797096933513232384
author Larkin, S
Ferraù, F
Karavitaki, N
Hernández-Ramírez, L
Ansorge, O
Grossman, A
Korbonits, M
author_facet Larkin, S
Ferraù, F
Karavitaki, N
Hernández-Ramírez, L
Ansorge, O
Grossman, A
Korbonits, M
author_sort Larkin, S
collection OXFORD
description OBJECTIVE: The pathogenetic mechanisms of sporadic somatotroph adenomas are not well understood, but derangements of the cAMP pathway have been implicated. Recent studies have identified L206R mutations in the alpha catalytic subunit of protein kinase A (PRKACA) in cortisol-producing adrenocortical adenomas and amplification of the beta catalytic subunit of protein kinase A PRKACB in acromegaly associated with Carney complex. Given that both adrenocortical adenomas and somatotroph adenomas are known to be reliant on the cAMP signalling pathway, we sought to determine the relevance of the L206R mutation in both PRKACA and PRKACB for the pathogenesis of sporadic somatotroph adenomas. DESIGN: Somatotroph adenoma specimens, both frozen and formalin-fixed, from patients who underwent surgery for their acromegaly between 1995 and 2012, were used in the study. METHODS: The DNA sequence at codon 206 of PRKACA and PRKACB was determined by PCR amplification and sequencing. The results were compared with patient characteristics, the mutational status of the GNAS complex locus and the tumour granulation pattern. RESULTS: No mutations at codon 206 of PRKACA or PRKACB were found in a total of 92 specimens, comprising both WT and mutant GNAS cases, and densely, sparsely and mixed granulation patterns. CONCLUSIONS: It is unlikely that mutation at this locus is involved in the pathogenesis of sporadic somatotroph adenoma; however, gene amplification or mutations at other loci or in other components of the cAMP signalling pathway, while unlikely, cannot be ruled out.
first_indexed 2024-03-07T04:48:32Z
format Journal article
id oxford-uuid:d4282a38-60ea-42f3-8877-fbfc614cee41
institution University of Oxford
language English
last_indexed 2024-03-07T04:48:32Z
publishDate 2014
record_format dspace
spelling oxford-uuid:d4282a38-60ea-42f3-8877-fbfc614cee412022-03-27T08:16:21ZSequence analysis of the catalytic subunit of PKA in somatotroph adenomas.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d4282a38-60ea-42f3-8877-fbfc614cee41EnglishSymplectic Elements at Oxford2014Larkin, SFerraù, FKaravitaki, NHernández-Ramírez, LAnsorge, OGrossman, AKorbonits, MOBJECTIVE: The pathogenetic mechanisms of sporadic somatotroph adenomas are not well understood, but derangements of the cAMP pathway have been implicated. Recent studies have identified L206R mutations in the alpha catalytic subunit of protein kinase A (PRKACA) in cortisol-producing adrenocortical adenomas and amplification of the beta catalytic subunit of protein kinase A PRKACB in acromegaly associated with Carney complex. Given that both adrenocortical adenomas and somatotroph adenomas are known to be reliant on the cAMP signalling pathway, we sought to determine the relevance of the L206R mutation in both PRKACA and PRKACB for the pathogenesis of sporadic somatotroph adenomas. DESIGN: Somatotroph adenoma specimens, both frozen and formalin-fixed, from patients who underwent surgery for their acromegaly between 1995 and 2012, were used in the study. METHODS: The DNA sequence at codon 206 of PRKACA and PRKACB was determined by PCR amplification and sequencing. The results were compared with patient characteristics, the mutational status of the GNAS complex locus and the tumour granulation pattern. RESULTS: No mutations at codon 206 of PRKACA or PRKACB were found in a total of 92 specimens, comprising both WT and mutant GNAS cases, and densely, sparsely and mixed granulation patterns. CONCLUSIONS: It is unlikely that mutation at this locus is involved in the pathogenesis of sporadic somatotroph adenoma; however, gene amplification or mutations at other loci or in other components of the cAMP signalling pathway, while unlikely, cannot be ruled out.
spellingShingle Larkin, S
Ferraù, F
Karavitaki, N
Hernández-Ramírez, L
Ansorge, O
Grossman, A
Korbonits, M
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
title Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
title_full Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
title_fullStr Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
title_full_unstemmed Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
title_short Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
title_sort sequence analysis of the catalytic subunit of pka in somatotroph adenomas
work_keys_str_mv AT larkins sequenceanalysisofthecatalyticsubunitofpkainsomatotrophadenomas
AT ferrauf sequenceanalysisofthecatalyticsubunitofpkainsomatotrophadenomas
AT karavitakin sequenceanalysisofthecatalyticsubunitofpkainsomatotrophadenomas
AT hernandezramirezl sequenceanalysisofthecatalyticsubunitofpkainsomatotrophadenomas
AT ansorgeo sequenceanalysisofthecatalyticsubunitofpkainsomatotrophadenomas
AT grossmana sequenceanalysisofthecatalyticsubunitofpkainsomatotrophadenomas
AT korbonitsm sequenceanalysisofthecatalyticsubunitofpkainsomatotrophadenomas